Status:
UNKNOWN
A Clinical Trial of Acyclovir for Viral Uveitis
Lead Sponsor:
Xiaomin Zhang
Conditions:
Uveitis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This project is designed to test the hypothesis that acyclovir is clinically useful for patients with refractory viral uveitis.
Detailed Description
Approval of the study was obtained from the hospital's ethical committee. The study design and methodology followed the tenets of Declaration of Helsinki. All patients were provided with written infor...
Eligibility Criteria
Inclusion
- Age between 18 and above.
- Chronic, vision threatening viral uveitis.
- Patients can't tolerate hormone therapy bacause of drug side effects.
- Consent to undergo anterior chamber tap and give aqueous for the study.
- Able to undergo relevant tests.
- Able to come for subsequent follow-up visits.
- Ability to provide informed consent.
Exclusion
- Patients who are allergic to ayclovir.
- Immunocompromised patients
- Positive for HIV, Hep B and Hep C
- Not keen on participating in the study
- Patients who are incapable, either by law or mental state, of giving consents in their own right.
- Patients who are either unable or unwilling to keep scheduled appointments and adhere to the other aspects of the protocol.
- Patients who are pregnant or breastfeeding.
- Any other specified reason as determined by the clinical investigator.
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03389191
Start Date
January 1 2017
End Date
December 1 2021
Last Update
April 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tianjin Medical University Eye Hospital
Tianjin, Tianjin Municipality, China, 300000